BTK inhibitor falters in multiple sclerosis trials

Nat Rev Neurol. 2024 May;20(5):255. doi: 10.1038/s41582-024-00958-8.
No abstract available

Publication types

  • News

MeSH terms

  • Agammaglobulinaemia Tyrosine Kinase* / antagonists & inhibitors
  • Clinical Trials as Topic / methods
  • Humans
  • Multiple Sclerosis* / drug therapy
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Protein-Tyrosine Kinases / antagonists & inhibitors

Substances

  • Agammaglobulinaemia Tyrosine Kinase
  • BTK protein, human
  • Protein-Tyrosine Kinases
  • Protein Kinase Inhibitors